| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular Endocrinology, Whittier Institute for Diabetes and Endocrinology La Jolla, California 92037
Address requests for reprints to: Shunichi Shimasaki, Ph.D., Department of Molecular Endocrinology, Whittier Institute, 9894 Genesee Avenue, La Jolla, California 92037.
Abstract
cDNA clones encoding a novel insulin-like growth factor-binding protein (IGFBP) purified from rat serum and human bone cell-conditioned medium have been isolated from rat liver and human placenta, liver, and ovary cDNA libraries. The deduced amino acid sequences of the cDNAs revealed a mature polypeptide consisting of 233 amino acids for the rat, while the human structure contains an additional four-amino acid sequence in the middle region of the molecule. This protein, now proposed to be named IGFBP-4, contains two extra cysteines compared with the previously characterized IGFBP-1, -2, and -3, but the alignment of the remaining 18 cysteines is conserved across the four IGFBPs. Amino acid sequence comparison among the four binding proteins within the rat species demonstrated that both the amino- and carboxy-terminal one thirds of the molecules are highly conserved, while the middle one third region, where no cysteines are present except for the two that exist in IGFBP-4, is the most divergent. The overall sequence homology among the four rat IGFBPs is very similar (53–59%), suggesting that their individual genes diverged from a single ancestral gene at about the same evolutionary time point.
Northern analysis of the IGFBP-4 mRNA in rat tissue demonstrated that transcription of the IGFBP-4 gene is highly active in the liver, although a single 2.6-kilobase IGFBP-4 mRNA band was detectable in all tissues examined, including adrenal, testis, spleen, heart, lung, kidney, liver, stomach, hypothalamus, and brain cortex.
FOOTNOTES
This work was supported by NICHHD Contract N01-HD-0-2902 and Program Project Grants HD-09690 and DK-18811 from the NIH.
Received for publication June 18, 1990. Revision received July 19, 1990. Accepted for publication July 24, 1990.
This article has been cited by other articles:
![]() |
Y. Ning, A. G. P. Schuller, C. A. Conover, and J. E. Pintar Insulin-Like Growth Factor (IGF) Binding Protein-4 Is Both a Positive and Negative Regulator of IGF Activity in Vivo Mol. Endocrinol., May 1, 2008; 22(5): 1213 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ning, B. Hoang, A. G. P. Schuller, T. P. Cominski, M.-S. Hsu, T. L. Wood, and J. E. Pintar Delayed Mammary Gland Involution in Mice with Mutation of the Insulin-Like Growth Factor Binding Protein 5 Gene Endocrinology, May 1, 2007; 148(5): 2138 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Bergman, C. J. Moravski, S. R. Edmondson, V. C. Russo, L. A. Bach, J. L. Wilkinson-Berka, and G. A. Werther Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2708 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Shimizu, J T Dickey, H Fukada, and W W Dickhoff Salmon serum 22 kDa insulin-like growth factor-binding protein (IGFBP) is IGFBP-1 J. Endocrinol., January 1, 2005; 184(1): 267 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Allar and T. L. Wood Expression of the Insulin-Like Growth Factor Binding Proteins during Postnatal Development of the Murine Mammary Gland Endocrinology, May 1, 2004; 145(5): 2467 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chamoun, D. Choi, A. B. Tavares, L. C. Udoff, E. Levitas, C. E. Resnick, R. G. Rosenfeld, and E. Y. Adashi Regulation of Granulosa Cell-Derived Insulin-Like Growth Factor Binding Proteins (IGFBPs): Role for Protein Kinase-C in the Pre- and Posttranslational Modulation of IGFBP-4 and IGFBP-5 Biol Reprod, September 1, 2002; 67(3): 1003 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, E. P. Smith, H. Kuroda, W. Banach, S. D. Chernausek, and J. A. Fagin Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy J. Biol. Chem., June 7, 2002; 277(24): 21285 - 21290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kuemmerle and B. Teng Regulation of IGFBP-4 levels in human intestinal muscle by an IGF-I-activated, confluence-dependent protease Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G975 - G982. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Ghoshal, Z. Xu, G. A. Wood, and M. C. Archer Induction of Hepatic Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) in Rats by Dietary n-6 Polyunsaturated Fatty Acids Exp Biol Med, November 1, 2000; 225(2): 128 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dahlfors and H. J. Arnqvist Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 Regulate the Expression of Insulin-Like Growth Factor-Binding Protein-3, -4, and -5 in Large Vessel Endothelial Cells Endocrinology, June 1, 2000; 141(6): 2062 - 2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chamoun, M. D. DeMoura, E. Levitas, C. E. Resnick, S. E. Gargosky, R. G. Rosenfeld, T. Matsumoto, and E. Y. Adashi Transcriptional and Posttranscriptional Regulation of Intraovarian Insulin-Like Growth Factor-Binding Proteins by Interleukin-1{beta} (IL-1{beta}): Evidence for IL-1{beta} as an Antiatretic Principal Endocrinology, August 1, 1999; 140(8): 3488 - 3495. [Abstract] [Full Text] |
||||
![]() |
Y. Gu, W.S. Branham, D.M. Sheehan, P.J. Webb, C.L. Moland, and R.D. Streck Tissue-Specific Expression of Messenger Ribonucleic Acids for Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins during Perinatal Development of the Rat Uterus Biol Reprod, May 1, 1999; 60(5): 1172 - 1182. [Abstract] [Full Text] |
||||
![]() |
H. Hirano, M. B. S. Lopes, E. R. Laws Jr., T. Asakura, M. Goto, J. E. Carpenter, L. R. Karns, and S. R. VandenBerg Insulin-like growth factor-1 content and pattern of expression correlateswith histopathologic grade in diffusely infiltrating astrocytomas Neuro Oncology, April 1, 1999; 1(2): 109 - 119. [Abstract] [PDF] |
||||
![]() |
T. A. Gautsch, S. M. Kandl, S. M. Donovan, and D. K. Layman Growth Hormone Promotes Somatic and Skeletal Muscle Growth Recovery in Rats Following Chronic Protein-Energy Malnutrition J. Nutr., April 1, 1999; 129(4): 828 - 837. [Abstract] [Full Text] |
||||
![]() |
S.-A. Wandji, T. L. Wood, J. Crawford, S. W. Levison, and J. M. Hammond Expression of Mouse Ovarian Insulin Growth Factor System Components During Follicular Development and Atresia Endocrinology, December 1, 1998; 139(12): 5205 - 5214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text] |
||||
![]() |
L. Putowski, R. M. Rohan, D. S. Choi, W. J. Scherzer, E. Ricciarelli, J. Mordacq, K. E. Mayo, and E. Y. Adashi Rat Ovarian Insulin-Like Growth Factor Binding Protein-4: A Hormone-Dependent Granulosa Cell-Derived Antigonadotropin Reproductive Sciences, May 1, 1997; 4(3): 144 - 151. [Abstract] [PDF] |
||||
![]() |
B. Tonshoff, D. R. Powell, D. Zhao, S. K. Durham, M. E. Coleman, H. M. Domene, W. F. Blum, R. C. Baxter, L. C. Moore, and F. J. Kaskel Decreased Hepatic Insulin-Like Growth Factor (IGF)-I and Increased IGF Binding Protein-1 and -2 Gene Expression in Experimental Uremia Endocrinology, March 1, 1997; 138(3): 938 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Band and B. I. Posner Phosphatidylinositol 3'-Kinase and p70s6k Are Required for Insulin but Not Bisperoxovanadium 1,10-Phenanthroline (bpV(phen)) Inhibition of Insulin-like Growth Factor Binding Protein Gene Expression. EVIDENCE FOR MEK-INDEPENDENT ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE BY bpV(phen) J. Biol. Chem., January 3, 1997; 272(1): 138 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dai, S. G. Widen, R. Mifflin, and P. Singh Cloning of the Functional Promoter for Human Insulin-Like Growth Factor Binding Protein-4 Gene: Endogenous Regulation Endocrinology, January 1, 1997; 138(1): 332 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Choi, L. T. Putowski, P. J. Fielder, R. G. Rosenfeld, R. M. Rohan, and E. Y. Adashi Characterization and Hormonal Regulation of Granulosa Cell-Derived Insulin-Like Growth Factor Binding Protein-4 Reproductive Sciences, May 1, 1996; 3(3): 145 - 151. [Abstract] [PDF] |
||||
![]() |
J. L. Fowlkes, D. M. Serra, C. K. Rosenberg, and K. M. Thrailkill Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) Functions as an IGF-reversible Inhibitor of IGFBP-4 Proteolysis J. Biol. Chem., November 17, 1995; 270(46): 27481 - 27488. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Conover, S. K. Durham, Jür. Zapf, F. R. Masiarz, and M. C. Kiefer Cleavage Analysis of Insulin-like Growth Factor (IGF)-dependent IGF-binding Protein-4 Proteolysis and Expression of Protease-resistant IGF-binding Protein-4 Mutants J. Biol. Chem., March 3, 1995; 270(9): 4395 - 4400. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |